Dechra Pharmaceuticals Plc (DPH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2018 | 06-2017 | 06-2016 | 06-2015 | 06-2014 | |
| Sales | 407,100 | 359,275 | 247,562 | 203,480 | 193,571 |
| Cost of Goods | 184,700 | 167,560 | 115,122 | 87,338 | 85,863 |
| Gross Profit | 222,400 | 191,715 | 132,440 | 116,142 | 107,708 |
| Operating Expenses | 182,400 | 155,035 | 105,802 | 89,662 | 82,083 |
| Operating Income | 40,000 | 36,680 | 26,638 | 26,480 | 25,625 |
| Interest Expense | 6,900 | 5,056 | 2,389 | 1,496 | 2,643 |
| Other Income | -4,200 | -3,062 | -9,701 | 822 | -1,540 |
| Pre-tax Income | 28,900 | 28,562 | 14,548 | 25,806 | 21,442 |
| Income Tax | -7,200 | 2,452 | 2,036 | 6,347 | 2,026 |
| Net Income Continuous | 36,100 | 26,110 | 12,512 | 19,459 | 19,416 |
| Net Income Discontinuous | N/A | N/A | N/A | 0 | 39,631 |
| Minority Interests | 0 | -5 | 156 | N/A | N/A |
| Net Income | $36,100 | $26,105 | $12,668 | $19,459 | $59,047 |
| EPS Basic Total Ops | 0.37 | 0.28 | 0.14 | 0.22 | 0.68 |
| EPS Basic Continuous Ops | 0.37 | 0.28 | 0.14 | 0.22 | 0.22 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.00 | 0.67 |
| EPS Diluted Total Ops | 0.37 | 0.28 | 0.14 | 0.22 | 0.67 |
| EPS Diluted Continuous Ops | 0.37 | 0.28 | 0.14 | 0.22 | 0.22 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.00 | 0.45 |
| EBITDA(a) | $89,900 | $62,621 | $42,252 | $48,840 | $44,622 |